Related Experiment Videos
Temperature-dependent drug release from large unilamellar liposomes
Cancer Drug Delivery
|January 1, 1984
Summary
Large unilamellar liposomes efficiently encapsulate anticancer drugs. These drug-filled liposomes release their contents rapidly and completely at a specific temperature (43°C) in serum.
Area of Science:
- Biochemistry
- Materials Science
- Pharmaceutical Sciences
Background:
- Liposomes are widely investigated as drug delivery systems.
- Controlling drug release from liposomes is crucial for therapeutic efficacy.
- Lipid phase-transition temperature influences liposome stability and drug release.
Purpose of the Study:
- To investigate the drug-release properties of large unilamellar liposomes near their phase-transition temperature.
- To determine the feasibility of temperature-triggered drug release for an anticancer agent.
Main Methods:
- Large unilamellar liposomes were prepared using dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol via reverse-phase evaporation.
- Encapsulation efficiency of cytosine [3H]-1-beta-arabinofuranoside was measured.
- Drug release was monitored in serum at temperatures around the lipid phase-transition temperature (41°C).
Main Results:
- Liposomes encapsulated 25-35% of the anticancer drug cytosine [3H]-1-beta-arabinofuranoside.
- Liposomes demonstrated stability in serum below 41°C.
- Complete drug release occurred within seconds upon reaching 43°C in serum.
- Cholesterol or phosphatidylglycerol addition altered drug release temperature and range.
Conclusions:
- Large unilamellar liposomes can encapsulate therapeutically relevant drug quantities.
- Rapid and complete drug release is achievable at a specific temperature (43°C) in serum.
- Liposome composition can be modified to tune drug release characteristics.